BioArctic AB

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

61.62%

Market Cap

-

P/E Ratio

26.92

Dividend Yield

0.64 %

Earnings per Share

1.05 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE27.3 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 12:51:36 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW27.3626.82
PREV. DAY'S PRICE26.66 (07/20)
CHANGE DAY BEFORE
+0.64
2.40 %
52 WEEK HIGH / LOW35.52 (02/18)16.77 (07/18)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.23-0.181.050.240.57
DIVIDENDS PER SHARE
0.000.000.180.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.64 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
103.07-26.92112.8647.80
PRICE - BOOK RATIO
22.6019.7014.01--
PRICE - SALES RATIO
38.4768.4913.77--
PRICE - CASH FLOW RATIO
76.52-19.23--
Further Key Figures

Master Data

WKN
A2H5GS
ISIN
SE0010323311
SYMBOL
B9A
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
BIOARCTIC AB B
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-6.09 %
1.35 %
-8.44 %
-12.01 %
61.62 %
10.60 %
118.36 %
-5.44 %
HIGH29.5030.6032.5235.5235.5235.5235.5235.52
LOW26.5626.4825.2625.2616.7711.886.2125.26

Dividende

pro Aktie

Company profile

BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors in 2003 and is headquartered in Stockholm, Sweden.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.